Status:
COMPLETED
CIRCAdian Rhythm of the IMMune Age IndeX (IMMAX)
Lead Sponsor:
Leibniz Research Centre for Working Environment and Human Factors
Conditions:
Healthy Subjects
Immune Cells (Mucosal and Systemic)
Eligibility:
All Genders
18+ years
Brief Summary
The goal of this observational study is to evaluate the influence of circadian rhythms on the determination of an individual's immune age. The biomarker IMMAX was calculated for 50 participants aged 2...
Eligibility Criteria
Inclusion
- aged \> 18 years
- knowledge of German or English sufficient to provide verbal explanations and obtain written consent
Exclusion
- exercise on the assessment day
- acute infection
- vaccination within the last 4 weeks
- autoimmune disease
- cancer
- drugs that may influence immune cell counts
- participation in other interventional studies during study period
Key Trial Info
Start Date :
December 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 22 2024
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT07169721
Start Date
December 1 2023
End Date
April 22 2024
Last Update
September 17 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Leibniz Research Centre for Working and Environment and Human Factors
Dortmund, Germany, 44139